Zobrazeno 1 - 10
of 399
pro vyhledávání: ''
Autor:
Jie, Chen, Chen, Li, Yuanjie, Cao, Li, Zhu, Bailin, Zhang, Jinqiang, You, Hailing, Hou, Jing, Wang, Zhiyong, Yuan
Publikováno v:
BMC Cancer. 22
Background Concurrent chemoradiotherapy is currently the standard of care for patients with locally advanced cervical cancer. However, even with the application of modern radiotherapy techniques, a considerable number of patients still develop distan
Autor:
Kuo-Hsing Chen, Kun-Huei Yeh, Ann-Lii Cheng, Yi-Hsin Liang, Been-Ren Lin, Chang-Tsu Yuan, Li Hui Tseng, Yu-Liang Chao, Liang-In Lin, Jin-Tung Liang
Publikováno v:
Br J Cancer
BACKGROUND: CpG island methylator phenotype (CIMP) represents a carcinogenesis pathway of colorectal cancer (CRC) and the association between CIMP CRC, molecular features and risk factors in East Asian population is less studied. METHODS: We prospect
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Purpose Several studies have evaluated the role of delayed initiation of adjuvant chemotherapy (AC) in breast cancer (BC), but the results have remained controversial and an optimal time has not been defined. Our aim was to determine the effect of ti
Publikováno v:
BMC Cancer
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Background The purpose was to examine the effect of negative lymph nodes (NLN) number on survival in stage III colon cancer. To reduce the interference of acute inflammation, we included patients with stage III colon cancer who had undergone elective
Autor:
Min, Shi, Zhongyin, Yang, Sheng, Lu, Wentao, Liu, Zhentian, Ni, Xuexin, Yao, Zichen, Hua, Runhua, Feng, Yanan, Zheng, Zhenqiang, Wang, Birendra Kumar, Sah, Mingmin, Chen, Zhenglun, Zhu, Changyu, He, Chen, Li, Jun, Zhang, Chao, Yan, Min, Yan, Zhenggang, Zhu
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cancer
BMC Cancer
Background In this study, we tried to access the efficacy and safety of oxaliplatin plus S-1 with intraperitoneal paclitaxel (PTX) for the treatment of Chinese advanced gastric cancer with peritoneal metastases. Patients and methods Thirty patients d
Autor:
Ryo Wada, Takuo Hayashi, Yuka Yanai, Shigeki Tomita, Sho Tsuyama, Kanako Ogura, Yoichi Akazawa, Toshiharu Matsumoto, Takashi Yao, Noboru Yatagai, Shu Hirai, Tsuyoshi Saito
Publikováno v:
Virchows Archiv. 478:413-426
Appendiceal mucinous tumors (AMTs) include low-grade mucinous appendiceal neoplasms (LAMNs), high-grade mucinous appendiceal neoplasms (HAMNs), and mucinous adenocarcinomas (MACs). We collected 51 AMT samples (LAMN: 34, HAMN: 8, MAC: 9). Three of the
Autor:
Simeon Uwimana, Yves Kalinijabo, Vincent Bours, Jeanne P. Uyisenga, Emile Karinganire, Costas C. Ainhoa, Leon Mutesa, Claire Josse, Ahmed Debit, Aimee P. Cyuzuzo, Yvan Butera, Nicole Umurungi
Publikováno v:
Hormones and Cancer. 11:240-249
Breast cancer is a complex disease, and it is the most common cause of morbidity and mortality among women worldwide. In Sub-Saharan Africa, the clinical characteristics and tumor profiles of breast cancer are still unknown. In the present study we a
Publikováno v:
Clinical and Translational Oncology. 23:526-535
Reduction of surgeries in axillary has been proved feasible in breast cancer with negative and limited involved axillary lymph nodes. However, for women with a heavy axillary burden, the extent of dissection is still arguable. From a total of 7042 pa
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 146:2231-2239
Adjuvant chemotherapy could improve the prognosis of stage II–III non-small cell lung cancer (NSCLC). However, its influences on stage IB were controversial. The purpose of this study was to investigate whether patients with stage IB NSCLC could be
Autor:
Zhao-Peng Zhang, Xiao Sun, Zhi-Qiang Shi, Zhimin Shao, Bin-Bin Cong, Xue-Er Wang, Yong-Sheng Wang
Publikováno v:
Breast Cancer Research and Treatment. 180:423-428
The aim of the study is to evaluate the optimal timing of sentinel lymph node biopsy (SLNB) in patients with clinical negative axillary lymph nodes (ALNs) before neoadjuvant therapy (NAT) and the feasibility of SLNB substituting for ALN dissection in